In 2005, the Federal Government introduced a free malaria treatment policy for pregnant women nationwide to reduce maternal mortality as the disease is responsible for 11 per cent of maternal deaths ...

A new study has found that a beloved spice could be meddling with how your body processes prescription drugs. The culprit? Cinnamon. Researchers at the University of Mississippi have discovered ...

A new study in the New England Journal of Medicine suggests that some people with early-stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab.

stock plummeted 20.2% following the company’s announcement that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on their Phase 1b study of VYN202, a treatment for moderate ...

A new study suggests the discontinuation of common asthma drug Flovent was linked to a higher rate of children halting inhaled steroid therapy altogether. In January 2024, a manufacturer stopped ...

Scientists at Scripps Research discover that apremilast, an FDA-approved anti-inflammatory drug, reduces both alcohol ...

There may be “substantial delays” between when a drug is granted accelerated approval ... Fund to Brigham and Women’s Hospital. Some study authors disclosed conflicts of interest.

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

COVID - 19: The Company reported $84 million in Spikevax® sales in the first quarter of 2025, which includes $29 million of U.S. sales and $55 million of international sales. As previously reported, ...

The study aimed at accessing the effects of Abivax treatment on HIV DNA in blood and in rectal tissue in HIV patients and was conducted at the Germans Trias i Pujol University Hospital Badalona in ...

Just a few months after buying Timber Pharma, LEO Pharma has revealed that the main drug it acquired as part of the deal has failed a phase 3 trial. Timber's lead candidate TMB-001 for rare skin ...